Insider filing · BIIB
Biogen Inc.
BIIB · Healthcare · 16 filings in 24 months
ticker →
Stephen A Sherwin sold $1.3M of Biogen (BIIB)
Executed Mar 7 2025, disclosed Mar 10 2025, 3 days later.
Value, as filed
$1.3M
8,760 sh × $150.02
Executed
Mar 7 2025
the trade date, as filed
Disclosed
Mar 10 2025
3 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
SS
Stephen A Sherwin
Director
profile →
Stephen A Sherwin (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Neurocrine Biosciences, Inc. (NBIX). The largest single filing was $4.1M of NBIX (25,000 sh across 5 lots, as filed), executed Jun 5.
The name
BIIBHealthcare · Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→